BOT-191

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameBOT-191
Drug Alias NameBOT-191
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionPlatelet-derived growth factor receptor beta inhibitors
TargetsPlatelet-derived growth factor receptor beta
Therapy Area/IndicationsRenal fibrosisLiver CirrhosisColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBiorion Technologies
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsRenal fibrosisLiver CirrhosisColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A